Michael Betel

Michael Betel is an esteemed patient advocate in the realm of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), currently serving as the Director of the Fatty Liver Alliance. His commitment to patient care and public health has seen him spearhead initiatives aimed at promoting awareness, early diagnosis, and effective intervention in liver diseases.

With a strong background in healthcare, Betel’s efforts are primarily centered around medical education and patient support. He coordinates the efforts of diverse stakeholders, including healthcare providers, patients, families, researchers, and the pharmaceutical industry, to foster a comprehensive and inclusive approach to liver disease management.

Betel’s leadership has played a key role in major events targeting primary care physicians on NAFLD and NASH, enabling them to better understand and address these conditions. His dedication to promoting knowledge and best practices extends to collaborative work with multiple grassroots organizations through the Liver Action Network under the guidance of the Global Liver Institute.

As an influential advocate, Michael Betel strives to improve resources and support for medical professionals, and more crucially, for patients impacted by NAFLD and NASH. His work with the Fatty Liver Alliance and other initiatives continues to be instrumental in driving a more informed, proactive, and compassionate approach to liver disease care.